Sort
16,300 grants matching “fatty liver disease”
Fatty Liver /Hepatic Insulin Resistance from High Fat Fe
$21,072Yale University · M01 · FY2004 · RR
EXCESS GLUCOSE PRODUCTION: GLYCOGEN OR TCA-CYCLE GLUCONEOGENESIS?
$20,916Eunsook Jin · Ut Southwestern Medical Center · P41 · FY2008 · RR
NON-ALCOHOLIC FATTY LIVER DISEASE, ETHNICITY AND HEPATIC METABOLISM
$20,916Jeff L Browning · Ut Southwestern Medical Center · P41 · FY2008 · RR
Developing chemoproteomic approaches to decipher the regulatory network of LRH-1, a nuclear receptor implicated in hepatic metabolism
$20,912Valentine Virginie Courouble · Scripps Florida · F31 · FY2021 · DK
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE WITH VITAMIN E SUPPLEMENTATION
$20,781Nancy F Butte · Baylor College Of Medicine · M01 · FY2006 · RR
MYOCARDIAL FUNCTION AND FFA METABOLISM IN HIV-METABOLIC SYNDROME
$20,779Kevin E Yarasheski · Washington University · M01 · FY2007 · RR
Brown adipose tissue lysosomal and neutral lipases in nonshivering thermogenesis
$20,645Yuxi Lin · Columbia University Health Sciences · F31 · FY2016 · DK
Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation
$20,594Joshua David Breidenbach · University Of Toledo Health Sci Campus · F31 · FY2022 · HL
How does mTOR sense lipid in vivo
$20,537Henrietta J Bains · Albert Einstein College Of Medicine · F31 · FY2023 · AG
Obesity Development: Role of Air Pollution and High Fat Diet
$20,502Qinghua Sun · Ohio State University · R21 · FY2010 · ES
Southern California Children's Environmental Health Center (SC-CEHC)
$20,390Rob S McConnell · University Of Southern California · P01 · FY2014 · ES
Adipose Tissue: Energizing Good Fat
$20,200Thale Cross Jarvis · Keystone Symposia · R13 · FY2023 · DK
CLINICAL TRIAL: SILYMARIN (LEGALON?) IN NON-CIRRHOTIC SUBJECTS WITH CHRONIC HEP
$20,125Roy L Hawke · Univ Of North Carolina Chapel Hill · M01 · FY2008 · RR
Neuroimmunometabolism: Obesity at the Crossroads between Neuroimmunity and Immunometabolism
$20,100Thale Cross Jarvis · Keystone Symposia · R13 · FY2022 · AI
STOPNASH Meeting
$20,000Miriam B. Vos · Emory University · R13 · FY2015 · DK
Cholesterol homeostasis in the vertebrate retina
$20,000Steven J. Fliesler · State University Of New York At Buffalo · R01 · FY2024 · EY
22nd Liver Sinusoid Meeting
$20,000Natalia Nieto · University Of Illinois At Chicago · R13 · FY2023 · AA
The Role of Alcohol in HIV Therapy Hepatotoxicity
$19,976Craig J McClain · University Of Louisville · R01 · FY2012 · AA
The role of dietary cholesterol in Nonalcoholic fatty liver disease through the action of gut microbiota
$19,939Jake Brenner Hermanson · University Of Wisconsin-Madison · F31 · FY2025 · DK
Daily Rhythms and Health: Obesity and Related Disorders
$19,880Julie S Pendergast · Vanderbilt University · K01 · FY2015 · DK
Determinants of Liver Metastasis
$19,749Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
The role of hepatic IKKi in regulating energy balance
$19,650Christina Lynn Sherry · University Of Michigan At Ann Arbor · F32 · FY2010 · DK
TREATMENT OF NONALCHOLIC STEATOHEPATITIS
$19,638Kris Kowdley · University Of Washington · M01 · FY2007 · RR
2018 Kern Lipid Conference
$19,500Robert H Eckel · University Of Colorado Denver · R13 · FY2018 · HL
NAD+ and metabolic flexibility
$19,438Samuel Klein · Washington University · R01 · FY2023 · DK